Cosmos Health News

Cosmos Health | 8-K/A: Cosmos Health Anticipated Letter from Nasdaq Regarding Form 10-Q and Disclosed About the Appointment of New Independent Registered Auditors(Amendment)

May 28 06:06 ET

Cosmos Health | NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB

May 16 16:35 ET

Cosmos Health | 8-K/A: Current report (Amendment)

May 3 12:55 ET

Cosmos Health | 8-K/A: Current report (Amendment)

May 2 06:08 ET

Cosmos Health | 8-K: Current report

Apr 26 16:37 ET

Cosmos Health | 8-K: Entered Into A Rights Agreement

Apr 25 17:27 ET

Cosmos Health | 8-K: Cosmos Health Receives Nasdaq Notice on Late Filing of Its Form 10-K

Apr 19 17:05 ET

Cosmos Health | NT 10-K: Others

Apr 2 16:37 ET

Cosmos Health | 8-K: Cosmos Health Receives a Non-Compliance Letter from Nasdaq and Company Defines Policies and Procedures for Related Party Transactions

Mar 22 16:30 ET

Cosmos Health | 424B3: Prospectus

Mar 7 16:37 ET

Cosmos Health | 424B3: Prospectus

Feb 29 16:41 ET

Cosmos Health | 4: Statement of changes in beneficial ownership of securities-Officer Siokas Grigorios

Feb 21 10:26 ET

Cosmos Health | 424B3: Prospectus

Feb 15 16:11 ET

Cosmos Health | SC 13G: Statement of acquisition of beneficial ownership by individuals-Armistice Capital, LLC(9.99%),Steven Boyd(9.99%)

Feb 14 15:38 ET

Cosmos Health | EFFECT: Others

Feb 9 06:04 ET

Cosmos Health | CORRESP: CORRESP

Feb 6 12:03 ET

Cosmos Health | UPLOAD: Others

Feb 5 12:03 ET

Cosmos Health | S-3: Registration statement for specified transactions by certain issuers

Jan 29 17:20 ET

Cosmos Health | 8-K: Cosmos Health Announces Acquisition of Licenses and Rights to 10 Generic Drugs for €3.2 Million

Jan 22 00:00 ET

Cosmos Health | 8-K/A: Cosmos Health Set for Substantial Growth from Acquisitions Completed in 2023 and Entered into a Warrant Exchange Agreement (Amendment)

Dec 29, 2023 00:00 ET